期刊文献+

小分子c-Met激酶抑制剂的研究进展

Progress on c-Met kinase inhibitors
原文传递
导出
摘要 c-Met激酶与肿瘤的发生、发展和转移密切相关。c-Met激酶小分子抑制剂的研究为多种类型肿瘤提供了一种新的靶向治疗手段。该文重点介绍近年来报道的不同结构类型的c-Met激酶小分子抑制剂,并对其活性和构效关系进行综述。 c-Met kinase contributes to tumorigenesis,tumor progression,and metastasis in numerous human malignancies.The development of small-molecule inhibitors of c-Met kinase has led to well-tolerated,targeted therapies for a growing number of cancer types.Recent developments in different chemical types of c-Met kinase inhibitors were highlighted in this view.The biological activity and the structure-activity relationship aspects were also described.
出处 《中国药物化学杂志》 CAS CSCD 2010年第5期426-433,共8页 Chinese Journal of Medicinal Chemistry
关键词 c-Met激酶 抑制剂 构效关系:抗肿瘤活性 c-Met kinase inhibitor structure-activity relationship antitumor activity
  • 相关文献

参考文献28

  • 1MIGLIORE C,GIORDANO S. Molecular cancer thera- py:can our expectation be MET? [J]. Eur J Cancer, 2008,44 (5) :641 - 651.
  • 2STELLRECHT C M, GANDHI V. MET receptor tyrosine kinase as a therapeutic anticancer target[ J]. Cancer Lett,2009,280( 1 ) : 1 - 14.
  • 3WAGH P K, PEACE B E,WALTZ S E. Met-related receptor tyrosine kinase Ron in tumor growth and metastasis [ J ]. Adv Cancer Res, 2008,100 : 1 - 33.
  • 4DUSSAULT I, BELLON S F. From concept to reality:the long road to c-Met and RON receptor tyrosine kinase inhibitors for the treatment of cancer[J]. Anticancer Agents Med Chem, 2009, 9 (2): 221 - 229.
  • 5SEIWERT T Y, JAGADEESWARAN R, FAORO L, et al. The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma[ J]. Cancer Res,2009,69(7) :3021 - 3031.
  • 6SCHIERING M, KNAPP S, MARCONI M, et al. Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a [ J ]. Proc Natl Acad Sci USA, 2003,100 ( 22 ) : 12654 - 12659.
  • 7KOBAYASHI S, ISA K, HAYASHI K, et al. K252a, a potent inhibitor of protein kinases, inhibits the migration of cerebellar granule cells in vitro[ J]. Brain Res Dev Brain Res,1995,90(1/2) :122- 128.
  • 8MOROTTI A, MILA S, ACCORNERO P, et al. K252a inhibits the oncogenic properties of Met, the HGF receptor[J]. Oncogene,2002,21 (32) :4885 - 4893.
  • 9WANG X, LE P, LIANG C, et al. Potent and selective inhibitors of the Met[ hepatocyte growth factor/ scatter factor (HGF/SF) receptor ] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion[ J]. Mol Cancer Ther, 2003,2 ( 11 ) : 1085 - 1092.
  • 10CHRISTENSEN J G, SCHRECHK R, BURROWS J, et al. A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo [ J]. Cancer Res ,2003,63( 21 ) :7345 - 7355.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部